All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Off Study Date | NCIT_C93610 | [The date (and time) when the study subject is removed from the study.] |
| Decreased Concomitant Drug Level | NCIT_C54358 | |
| Performed Study Subject Milestone Off Study Reason Code | NCIT_C93966 | [A coded value specifying why the subject is removed from a study.] |
| Off Study Reason Code | NCIT_C93611 | [A coded value specifying why the subject is removed from a study.] |
| Performed Study Subject Milestone Registration Date | NCIT_C93967 | [The date (and time) the subject has been registered to the study assuming they have finished screening and have been found eligible.] |
| Study Registration Date | NCIT_C93681 | [The date (and time) the subject has been registered to the study.] |
| Performed Study Subject Milestone Study Reference Date Range | NCIT_C93968 | [The date and time span used to indicate the start and end of the study for a subject.] |
| Study Reference Date Range | NCIT_C93680 | [The date and time span used to indicate the start and end of the study in relation to another time point.] |
| Performed Substance Administration Change Reason | NCIT_C93969 | [The rationale for changing the substance administration in relation to the previous substance administration.] |
| Change Reason | NCIT_C93529 | [The rationale for why an entity or event is changed.] |
| Stage IV Adult Soft Tissue Sarcoma AJCC v7 | NCIT_C7821 | [Stage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 7th ed.)] |
| Stage IV Soft Tissue Sarcoma AJCC v7 | NCIT_C8586 | [Stage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 7th ed.)] |
| Recurrent Adult Soft Tissue Sarcoma | NCIT_C7822 | [A soft tissue sarcoma occurring in adults that has recurred after a period of remission.] |
| Recurrent Soft Tissue Sarcoma | NCIT_C139002 | [The reemergence of soft tissue sarcoma after a period of remission.] |
| Stage I Renal Cell Cancer AJCC v6 and v7 | NCIT_C7823 | [Stage I includes: T1, N0, M0. T1: Lesions have been divided into T1a and T1b. T1a is defined as tumor 4 cm or less in greatest dimension, limited to the kidney. T1b is defined as tumor greater than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.)] |
| Renal Cell Cancer by AJCC v6 Stage | NCIT_C90343 | [A term that refers to the staging of renal cell cancer according to the American Joint Committee on Cancer, 6th edition.] |
| Renal Cell Cancer by AJCC v7 Stage | NCIT_C91201 | [A term that refers to the staging of renal cell cancer according to the American Joint Committee on Cancer, 7th edition.] |
| Second-Line Therapy | NCIT_C54350 | [The second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.] |
| Line of Therapy | NCIT_C133518 | [The sequence of therapies administered to a patient.] |
| Stage II Renal Cell Cancer AJCC v6 | NCIT_C7824 | [Stage II includes: T2, N0, M0. T2: Tumor more than 7 cm in greatest dimension limited to the kidney. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 6th Ed.) - 2003] |